JPMORGAN CHASE & CO - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 25 filers reported holding ATYR PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$78,434
-38.8%
49,642
-16.3%
0.00%
Q2 2023$128,086
-54.7%
59,299
-56.0%
0.00%
Q1 2023$283,000
+4716566.7%
134,868
+5093.2%
0.00%
Q4 2022$62,597
+43183.3%
0.00%
Q3 2020$06
+20.0%
0.00%
Q2 2020$050.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 624,000$1,3672.16%
Tikvah Management LLC 1,350,833$2,958,3241.41%
VR Adviser, LLC 1,171,436$2,565,4450.43%
TANG CAPITAL MANAGEMENT LLC 123,430$270,3120.04%
FEDERATED HERMES, INC. 5,231,600$11,457,2040.03%
Alyeska Investment Group, L.P. 1,378,747$3,019,4560.03%
Walleye Capital LLC 750,000$1,642,5000.03%
Tower Research Capital LLC (TRC) 17,443$380.00%
CITIGROUP INC 428,460$938,3270.00%
PFS Partners, LLC 406$8900.00%
View complete list of ATYR PHARMA INC shareholders